These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7272932)

  • 21. Clinical pharmacology of tamoxifen and N-desmethyltamoxifen in patients with advanced breast cancer.
    Wilkinson P; Ribeiro G; Adam H; Patterson J
    Cancer Chemother Pharmacol; 1980; 5(2):109-11. PubMed ID: 7471314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiestrogen therapy of breast cancer.
    Lippman ME
    Semin Oncol; 1983 Dec; 10(4 Suppl 4):11-9. PubMed ID: 6367050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase I pharmacokinetics study of lapatinib and tamoxifen in metastatic breast cancer (EORTC 10053 Lapatam study).
    Fumoleau P; Koch KM; Brain E; Lokiec F; Rezai K; Awada A; Hayward L; Werutsky G; Bogaerts J; Marréaud S; Cardoso F
    Breast; 2014 Oct; 23(5):663-9. PubMed ID: 25065668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of recurrent breast cancer responding to long-term administration of tamoxifen].
    Yayoi E; Kobayashi T; Inaji H; Maeura Y; Mori T
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1683-6. PubMed ID: 6433801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination and pharmacology of a new hydroxylated metabolite of tamoxifen observed in patient sera during therapy for advanced breast cancer.
    Jordan VC; Bain RR; Brown RR; Gosden B; Santos MA
    Cancer Res; 1983 Mar; 43(3):1446-50. PubMed ID: 6825112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum elimination half-life of tamoxifen and its metabolites in patients with advanced breast cancer.
    de Vos D; Slee PH; Stevenson D; Briggs RJ
    Cancer Chemother Pharmacol; 1992; 31(1):76-8. PubMed ID: 1458563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tamoxifen therapy in premenopausal women with metastatic breast cancer.
    Planting AS; Alexieva-Figusch J; Blonk-vdWijst J; van Putten WL
    Cancer Treat Rep; 1985 Apr; 69(4):363-8. PubMed ID: 3995508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic profile of intramuscular fulvestrant in advanced breast cancer.
    Robertson JF; Erikstein B; Osborne KC; Pippen J; Come SE; Parker LM; Gertler S; Harrison MP; Clarke DA
    Clin Pharmacokinet; 2004; 43(8):529-38. PubMed ID: 15170367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Metastatic breast cancer: a comparative study of the efficacy of tamoxifen and the sequential administration of tamoxifen and medroxyprogesterone acetate].
    Giralt E; Jouve M; Palangie T; Bretaudeau B; Asselain B; Magdelenat H; Merle S; Zajdela A; Pouillart P
    Bull Cancer; 1984; 71(1):22-9. PubMed ID: 6324934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-adjustment study of tamoxifen based on CYP2D6 genotypes in Japanese breast cancer patients.
    Kiyotani K; Mushiroda T; Imamura CK; Tanigawara Y; Hosono N; Kubo M; Sasa M; Nakamura Y; Zembutsu H
    Breast Cancer Res Treat; 2012 Jan; 131(1):137-45. PubMed ID: 21947681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tamoxifen (antiestrogen) therapy in advanced breast cancer.
    Kiang DT; Kennedy BJ
    Ann Intern Med; 1977 Dec; 87(6):687-90. PubMed ID: 931204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tamoxifen and its main metabolites serum and tissue concentrations in breast cancer women.
    Furlanut M; Franceschi L; Pasqual E; Bacchetti S; Poz D; Giorda G; Cagol P
    Ther Drug Monit; 2007 Jun; 29(3):349-52. PubMed ID: 17529893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association.
    Muss HB; Wells HB; Paschold EH; Black WR; Cooper MR; Capizzi RL; Christian R; Cruz JM; Jackson DV; Powell BL
    J Clin Oncol; 1988 Jul; 6(7):1098-106. PubMed ID: 3292710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers.
    Decensi A; Robertson C; Viale G; Pigatto F; Johansson H; Kisanga ER; Veronesi P; Torrisi R; Cazzaniga M; Mora S; Sandri MT; Pelosi G; Luini A; Goldhirsch A; Lien EA; Veronesi U
    J Natl Cancer Inst; 2003 Jun; 95(11):779-90. PubMed ID: 12783932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective case series of women with estrogen receptor-positive breast cancer: levels of tamoxifen metabolites in controlled ovarian stimulation with high-dose tamoxifen.
    Balkenende EM; Dahhan T; Linn SC; Jager NG; Beijnen JH; Goddijn M
    Hum Reprod; 2013 Apr; 28(4):953-9. PubMed ID: 23335608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A comparison of two doses of tamoxifen in patients with advanced breast cancer: 20 mg/day versus 40 mg/day].
    Takatsuka Y; Yayoi E; Inaji H; Aikawa T
    Gan To Kagaku Ryoho; 1989 May; 16(5):2093-7. PubMed ID: 2658841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum concentrations of tamoxifen and major metabolite during long-term nolvadex therapy, correlated with clinical response.
    Patterson JS; Settatree RS; Adam HK; Kemp JV
    Eur J Cancer (1965); 1980; Suppl 1():89-92. PubMed ID: 7318875
    [No Abstract]   [Full Text] [Related]  

  • 38. Pronounced Interindividual But Not Intraindividual Variation in Tamoxifen and Metabolite Levels in Plasma During Adjuvant Treatment of Women With Early Breast Cancer.
    Fotoohi AK; Karim H; Lafolie P; Pohanka A; Östervall J; Hatschek T; Vitols S
    Ther Drug Monit; 2016 Apr; 38(2):239-45. PubMed ID: 26485084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical evaluation of the antioestrogenic agent tamoxifen in the treatment of metastatic breast cancer (author's transl)].
    Szepesi T; Czech W
    Wien Klin Wochenschr; 1978 Feb; 90(4):133-41. PubMed ID: 625990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma levels of tamoxifen, N-desmethyl tamoxifen and anastrozole in a patient with metastatic breast cancer and chronic hemodialysis.
    Langenegger T; Wahl P; Schiesser D; Thürlimann B
    Breast Cancer Res Treat; 2006 Nov; 100(2):177-81. PubMed ID: 16688477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.